China: C-Bridge backs pharma merger; Dadao closes Series B

China: C-Bridge backs pharma merger; Dadao closes Series B

24 March, 2017

C-Bridge Capital Partners LLC China Renaissance China Renaissance Private Equity Fund Dadao Financial I-Bridge Capital PAG Sequoia Capital China Tasly Holding Group Tianjing Biopharma Technology Tianzhenshi Biotechnology Company

Printed by Unregistered user on Thu, 25 Dec 2025 21:59:34 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Global investors bet on Chinese AI as Wall Street fears bubble

Viewpoint: Hong Kong IPO market eyes continued recovery after comeback year 2025